Qinghua Zhang

Qinghua Zhang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in Cellular Signalling
Verified
Journal Article
Closed access
YYYang Yu
Yang Yu
XLXinghui Li
Xinghui Li
XWXiuquan Wu
Xiuquan Wu
XLXinglong Li
Xinglong Li
JWJialiang Wei
Jialiang Wei
QZQinghua Zhang
Qinghua Zhang

19 April 2021 in Journal of Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
QZQingping Zhang
Qingping Zhang
BXBinchu Xu
Binchu Xu
FHFulan Hu
Fulan Hu
XCXianjin Chen
Xianjin Chen
XLXinmin Liu
Xinmin Liu
YZYou Zuo
You Zuo
The present study aimed to detect the effect of tenascin C (TNC) on cell function and chemosensitivity to paclitaxel and phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling in glioma cells.Human glioma cells U87, LN-229, T98G and U251 and normal human astrocytes were obtained, in which TNC expression was detected. The U87 cells and U251 cells were chosen and infected with lentivirus of control overexpression, TNC overexpression, control knockdown, and TNC knockdown for functional experiments. Rescue experiments were then performed to evaluate the effect of PI3K/AKT activator 740 Y-P on cell function and chemosensitivity to paclitaxel in TNC knockdown U251 cells. TNC mRNA and protein expression was elevated in glioma cells, including U87, LN-229, U251 and T98G cells, compared to normal human astrocytes. In U87 and U251 cells, TNC promoted proliferation while inhibiting apoptosis. In addition, TNC upregulated PI3K and p-AKT protein expression in U87 and U251 cells. As for chemosensitivity, TNC increased relative viability in U251 cells treated with 400 ng/mL and 800 ng/mL paclitaxel. In terms of stemness, TNC increased the sphere number per 1000 cells, CD44+CD133+ cell percentage and 1/stem cell frequency (assessed by extreme limiting dilution analysis) in U251 cells. In rescue experiments, 740 Y-P reduced the effect of TNC on proliferation, apoptosis, chemosensitivity to paclitaxel, and stemness in U251 cells. TNC acts as an oncogenic factor by promoting cancer cell proliferation and stemness while inhibiting apoptosis and chemosensitivity to paclitaxel in glioma via modulation of PI3K/AKT signaling.

24 January 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
YYYijian Yang
Yijian Yang
QOQian Ouyang
Qian Ouyang
YSYaxin Sun
Yaxin Sun
ALAijun Liang
Aijun Liang
JWJunqiang Wang
Junqiang Wang
Gelei XiaoGelei Xiao
Gelei Xiao
Aims: Intraventricular hemorrhage (IVH) has a high mortality and disability rate and poses significant clinical challenges, which often leads to hydrocephalus and neurological dysfunction. Emerging evidence implicates dysfunction of the glymphatic‐meningeal lymphatic‐deep cervical lymphatic system in the pathogenesis of post‐IVH hydrocephalus. Therapeutic hypothermia (TH) holds promise for mitigating these sequelae. This study investigates the potential of TH to ameliorate IVH‐induced hydrocephalus and neurological dysfunction, while elucidating its underlying mechanisms. Methods: Rat models of IVH are established by intraventricular injection of autologous blood. TH, deep cervical lymph nodes (dCLNs) ligation, and intraperitoneal injection of AMPK inhibitor are used to intervene. Results: In rat models of IVH, TH alleviates neurological dysfunction and attenuates hydrocephalus and pathology damage. TH protects physiological function and maintains normal structure of the glymphatic system. TH improves function and structure of the meningeal lymphatic system and promotes drainage of the deep cervical lymphatic system. TH upregulates RTN3, facilitates phosphorylation of AMPK, and suppresses ERS. All the above effects are reversed by ligation of dCLNs and AMPK inhibitor. Conclusion: TH alleviates hydrocephalus and neurological dysfunction post IVH by enhancing drainage of the glymphatic‐meningeal lymphatic‐deep cervical lymphatic system. The RTN3/AMPK/ERS pathway may be the proposed mechanism mediating this effect. TH is expected to become a novel therapeutic strategy for IVH.

22 February 2024 in Experimental Neurology
Verified
Journal Article
Open access
LWLi-Bin Wang
Li-Bin Wang
BLBao-Ying Liao
Bao-Ying Liao
YLYong-Jun Li
Yong-Jun Li
ZWZhen-Hai Wang
Zhen-Hai Wang
YYYang Yu
Yang Yu
QZQinghua Zhang
Qinghua Zhang
Demyelination is a proper syndrome in plenty of central nervous system (CNS) diseases, which is the main obstacle to recovery and still lacks an effective treatment. To overcome the limitations of the brain-blood barrier on drug permeability, we modified an exosome secreted by neural stem cells (NSCs), which had transfected with lentivirus armed with platelet-derived growth factors A (PDGFA)-ligand. Through the in vivo and in vitro exosomes targeting test, the migration ability to the lesion areas and OPCs significantly improved after ligand modification. Furthermore, the targeted exosomes loaded with 3,5, 30-L-triiodothyronine (T3) have a critical myelination ability in CNS development, administrated to the cuprizone animal model treatment. The data shows that the novel drug vector loaded with T3 significantly promotes remyelination compared with T3 alone. At the same time, it improved the CNS microenvironment by reducing astrogliosis, inhibiting pro-inflammatory microglia, and alleviating axon damage. This investigation provides a straightforward strategy to produce a targeting exosome and indicates a possible therapeutic manner for demyelinating disease.

26 September 2022 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
YYYijian Yang
Yijian Yang
CWChuansen Wang
Chuansen Wang
RCRui Chen
Rui Chen
YWYuchang Wang
Yuchang Wang
CTChangwu Tan
Changwu Tan
Gelei XiaoGelei Xiao
Gelei Xiao
Hydrocephalus is mainly characterized by excessive production or impaired absorption of cerebrospinal fluid that causes ventricular dilation and intracranial hypertension. Astrocytes are the key response cells to inflammation in the central nervous system. In hydrocephalus, astrocytes are activated and show dual characteristics depending on the period of development of the disease. They can suppress the disease in the early stage and may aggravate it in the late stage. More evidence suggests that therapeutics targeting astrocytes may be promising for hydrocephalus. In this review, based on previous studies, we summarize different forms of hydrocephalus-induced astrocyte reactivity and the corresponding function of these responses in hydrocephalus. We also discuss the therapeutic effects of astrocyte regulation on hydrocephalus in experimental studies.

5 October 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SJSong Ji-Wei
Song Ji-Wei
LZLiu Zi-Ying
Liu Zi-Ying
TXTao Xiang
Tao Xiang
YYYu Yang
Yu Yang
ZJZhao Ju-Fen
Zhao Ju-Fen
QZQinghua Zhang
Qinghua Zhang